ACD440 Gel in Peripheral Neuropathic Pain
NCT05416931
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Peripheral Neuropathic Pain
Interventions
DRUG:
ACD440 Gel 14mg/g
DRUG:
Placebo Gel
Sponsor
AlzeCure Pharma